公开(公告)号：US20200215149A1

公开(公告)日：2020-07-09

申请号：US16242982

申请日：2019-01-08

申请人： Christopher David Thompson

发明人： Christopher David Thompson

IPC分类号： A61K38/05 ,  A61K31/047 ,  A61K9/00 ,  A61K9/68 ,  A61K31/7068 ,  A61K31/522

摘要： A composition comprising a combination of N-Phenylacetyl-L-prolylglycine ethyl ester and cannabidiol for oral administration to humans and other animals and a method for administering said composition are described. The composition provides synergistic nootropic benefits to the user, resulting in enhanced cognitive functions, such as increased focus, creativity, memory recall, and memory consolidation, among other cognitive functions. The composition generally does not cause side effects in the users and generally does not cause the user to develop tolerance to its nootropic effects. The composition optionally comprises a compound containing choline or a choline prodrug to supply choline to the brain of the user for the production of the neurotransmitter acetylcholine, and may also optionally comprise caffeine.

公开(公告)号：US20200222353A1

公开(公告)日：2020-07-16

申请号：US16247513

申请日：2019-01-14

申请人： Christopher David Thompson

发明人： Christopher David Thompson

IPC分类号： A61K31/22 ,  A61K31/20

摘要： A composition comprising a combination of sodium beta-hydroxybutyrate, magnesium beta-hydroxybutyrate, potassium beta-hydroxybutyrate, calcium beta-hydroxybutyrate, and at least one ketone ester for oral administration to humans and other animals, as well as a method for administering said composition for enhanced physical or cognitive capabilities, physical endurance, or post-exercise recovery are described. The composition provides electrolytes to replace electrolytes lost during intense or extended physical activity to reduce the likelihood of cramps, muscle spasms, or fatigue from depletion of electrolytes. The composition concurrently provides ketone bodies, which raise the level of ketone bodies in the bloodstream and induce ketosis (>0.5 mM of ketone bodies in the bloodstream) and provide an alternative energy source to glycogen during physical activity. The composition generally does not cause side effects or discomfort in the user. The composition may optionally comprise at least one medium-chain triglyceride (MCT).